Our website have detected that you are using an outdated browser that will prevent you from accessing certain features. Bővebb információért kattintson.
Cart
Az Ön kosara

BEFEKTETŐI KAPCSOLATOK

Itt találja mindazokat az információkat, amelyek betekintést nyújtanak a Zinzino pénzügyi eredményeibe és stratégiai irányába.


ZINZINO AB (PUBL): INTERIM REPORT FIRST QUARTER 2022

MAINTAINED SALES LEVEL WITH SATISFACTORY PROFITABILITY Revenues during the first quarter of 2022 amounted to SEK 334.4 (333.4) million, which corresponded to 0.3% (38.0%) growth compared with the corresponding period last year. The EBITDA result amounted to SEK 25.8 (37.3) million and the EBITDA margin to 7.7% (11.2%). It showed that the company managed to maintain sales levels combined with good profitability despite the impact of external conditions with increased costs related to raw materials and transport, covid outbreaks among distributors and effects of the war between Russia and Tudjon meg többet »

Közzétett: 13 máj. PDF letöltése


Zinzino AB (PUBL): Preliminary Sales Report April 2022

Zinzino group revenue decreased with a total of 5%, compared with the previous year. The revenue in April for Zinzino's sales markets decreased by 3% and amounted to SEK 95.4 (98.7) million. Faun Pharma's external sales decreased by 28% and amounted to SEK 5.6 (7.8) million. Overall, the Group decreased revenues by 5% to SEK 101.0 (106.5) million compared with the previous year. Accumulated revenue for January – April 2022 decreased by 1% to SEK 435.4 (439.9) million. Revenues were distributed as follows: Regions, mSEK 22-apr 21-apr Change YTD 2022 YTD 2021 Change Tudjon meg többet »

Közzétett: 4 máj. PDF letöltése


Annual Report 2021 Zinzino AB (PUBL)

Zinzino (publ) announces that the Annual Report for 2021 is now published in Swedish at the company’s website, zinzino.com. An English version will be published within approximately 45 days.  The 2022 Annual General Meeting will be held at the company's premises at Hulda Mellgrens gata 5 in Västra Frölunda on 31 May at 13.30. For further information about the Annual General Meeting, please refer to the company's website www.zinzino.com. The Nomination Committee's proposals for Board members, the Board's fees and auditors are presented in the notice convening the Annual General Meeting. Tudjon meg többet »

Közzétett: 3 máj. PDF letöltése


Notice of Annual General Meeting of Zinzino AB on May 31, 2022

The shareholders of Zinzino AB (publ) are hereby summoned to the Annual General Meeting on Tuesday, May 31, 2022 at 13.30 in the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 13.15. It is the company's ambition to broadcast the meeting on the web to be able to attend the meeting at a distance. RIGHT TO PARTICIPATE IN THE ANNUAL GENERAL MEETING Shareholders who wish to participate in the Annual General Meeting shall be entered in the share register kept by Euroclear Sweden AB as of Monday, May 20, 2022, and no later than Monday, May 30, 2022, Tudjon meg többet »

Közzétett: 29 ápr. PDF letöltése


Zinzino announces the launch of Singapore as next step in their global expansion

Zinzino is very proud to announce the launch of its business in Singapore on April 7, 2022 as a strategic next step in the company’s global expansion plan.  After several years of preparing the launch of the Singapore market and having carried out multiple country establishment processes in recent years, Zinzino has learned the importance of ensuring thorough preparatory work and adapting to the local conditions in each market.  Profitable growth is an important business strategy for the global, direct selling company within test-based, scientifically proven nutrition. During 2021 the Tudjon meg többet »

Közzétett: 7 ápr. PDF letöltése


ZINZINO AB (PUBL): Zinzino acquires brand portfolio with Swiss skincare and supplements

Zinzino, the global health and wellness brand from Scandinavia, has acquired the Swiss companies Enhanzz Global AG and Enhanzz IP AG, including their skincare brand HANZZ+HEIDII and multifunctional nutrition label YU. This is a strategic and important step in Zinzino’s growth plans, with a focus on enhancing personal health and wellness on a global level with cutting-edge biotechnology and a groundbreaking product portfolio distributed through direct sales. Enhanzz is an innovative direct sales company from Switzerland specializing in exclusive, natural and vegan skincare products. The Tudjon meg többet »

Közzétett: 6 ápr. PDF letöltése


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2022

Zinzino group revenue in Q1 were unchanged compared with the previous year. The revenue in March for Zinzino's sales markets decreased by 3% and amounted to SEK 118.1 (121.8) million. Faun Pharma's external sales increased by 87% and amounted to SEK 9.7 (5.2) million. Overall, the Group increased revenues by 1% to SEK 127.8 (127.0) million compared with the previous year. The group revenue for Q1 2022 were unchanged compared with the first quarter last year and amounted to SEK 332.6 (333.4) million. Revenues were distributed as follows: Regions, mSEK 22-mar 21-mar Change Tudjon meg többet »

Közzétett: 5 ápr. PDF letöltése


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2022

Zinzino group revenue decreased with a total of 5%, compared with the previous year. The revenue in February for Zinzino's sales markets decreased by 4% and amounted to SEK 88.5 (92.6) million. Faun Pharma's external sales decreased by 7% and amounted to SEK 6.3 (6.8) million. Overall, the Group decreased revenues by 5% to SEK 94.8 (99.4) million compared with the previous year. Accumulated revenue for January – February 2022 decreased by 1% to SEK 204.5 (206.4) million. Revenues were distributed as follows: Regions,MSEK 22-Feb 21-Feb Change YTD 2022 YTD 2021 Change Tudjon meg többet »

Közzétett: 3 márc. PDF letöltése


ZINZINO AB (PUBL): YEAR-END REPORT 2021

20% SALES GROWTH AND RECORD RESULTS 2021 – SIGNIFICANTLY INCREASED DIVIDEND AT SEK 2 / SHARE PROPOSED For the full year 2021 the total revenues amounted to SEK 1,370.6 (1,138.6) million, which corresponded to 20% growth compared with the previous year. EBITDA increased to SEK 137.6 (108.5) million and the EBITDA margin to 10.0% (9.5%). The margin improvement for the year was mainly the result of increased profitability at the gross level in combination with economies of scale because of improved efficiency in IT systems and in the organisation as a whole. The good profitability over the Tudjon meg többet »

Közzétett: 28 febr. PDF letöltése


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2022

Zinzino group revenue increased with a total of 2 %, compared with the previous year. The revenue in January for Zinzino's sales markets remained at the same level as last year and amounted to SEK 102.2 (101.7) million. Faun Pharma's external sales increased by 26% and amounted to SEK 6.7 (5.3) million. Overall, the Group increased revenues by 2% to SEK 108.9 (107.0) million compared with the previous year. Revenues were distributed as follows: Regions,MSEK 22-jan 21-jan Change The Nordics 26.0 30.6 -15% Central Europe 18.4 18.5 -1% East Tudjon meg többet »

Közzétett: 3 febr. PDF letöltése


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2021

Strong sales growth during 2021; Zinzino group revenue increased with a total of 15% in Q4 and 20% for the full year 2021, compared with the previous year. The revenue in December for Zinzino's sales markets increased by 6% to SEK 135.2 (127.3) million due to solid growth in several regions. Faun Pharma's external sales decreased by 38% and amounted to SEK 4.0 (6.5) million. Overall, the Group increased revenues by 4% to SEK 139.2 (133.8) million compared with the previous year. The fourth quarter of 2021 became a solid quarter; the Zinzino based revenue in October – December increased by Tudjon meg többet »

Közzétett: 5 jan. PDF letöltése


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT NOVEMBER 2021

Strong sales growth during November; Zinzino group revenue increased with a total of 48%, compared with the previous year. The revenue in November for Zinzino’s sales markets increased by 49% to SEK 140.7 (94.6) million due to strong growth in several regions. Faun Pharma’s external sales increased by 28% and amounted to SEK 5.5 (4.3) million. Overall, the Group increased revenues by 48% to SEK 146.2 (98.9) million compared with the previous year. Accumulated revenue for January – November 2021 increased by 22% to SEK 1221.5 (1004.8) million. Revenues were distributed as follows: Tudjon meg többet »

Közzétett: 3 dec. PDF letöltése


ZINZINO AB (PUBL): INTERIM REPORT THIRD QUARTER 2021

FURTHER INCREASED PROFIT FORECAST AFTER ANOTHER STRONG QUARTER The third quarter of 2021 was yet another quarter in which good sales growth was combined with high profitability. Total revenues in the Group increased by 11% and amounted to SEK 313.6 (281.8) million. EBITDA result amounted to SEK 40.4 (28.8) million for the quarter and the EBITDA margin amounted to 12.9% (10.2%). During the quarter, Taiwan achieved full market status. In addition, after the end of the quarter a new test concept for Vitamin D levels was launched with the introduction of the new products Vitamin D Test and Tudjon meg többet »

Közzétett: 19 nov. PDF letöltése


ZINZINO AB (PUBL): MEMBERS OF THE NOMINATION COMMITTEE FOR ZINZINO AB'S ANNUAL GENERAL MEETING IN 2022

In accordance with decision by the Annual General Meeting, Zinzino AB’s Nomination Committee shall consist of three members. The members are selected by the two largest shareholders in the company that wish to participate in the committee. In addition, the Chairman of the Board is to be appointed to the Nomination Committee. In accordance with the above principles, the Nomination Committee consists of the following three members: • Hans Jacobsson, chairman of the board of Zinzino AB • Magnus Götenfelt, representing Saele Invest AS och the Saele family • Cecilia Halldner, Tudjon meg többet »

Közzétett: 18 nov. PDF letöltése


ZINZINO AB (PUBL): Zinzino announces the launch of South Africa as next step in their global expansion

Zinzino is very proud to announce the launch of its business in South Africa on November 9, 2021, as a strategic part of the company’s global expansion strategy. After several years of preparing the launch of the South African market and having carried out multiple country establishment processes in recent years, Zinzino has learned the importance of ensuring thorough preparatory work and adapting to the local conditions in each market. Profitable growth is an important business strategy for the e-commerce-based health tech company Zinzino. During 2020 the company sales target was Tudjon meg többet »

Közzétett: 9 nov. PDF letöltése


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2021

Zinzino group revenue decreased with a total of 3%, compared with the previous year. The revenue in October for Zinzino's sales markets stayed on the same level as last year and amounted to SEK 101.2 (100.8) million. Faun Pharma's external sales decreased by 46% and amounted to SEK 3.7 (6.9) million. Overall, the Group decreased revenues by 3% to SEK 104.9 (107.7) million compared with the previous year. Accumulated revenue for January – October 2021 increased by 19% to SEK 1074.3 (905.9) million. Revenues were distributed as follows: Regions,MSEK 21-okt 20-okt Change YTD Tudjon meg többet »

Közzétett: 3 nov. PDF letöltése


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2021

Solid sales growth during Q3; Zinzino group revenue increased with a total of 11%, compared with the previous year. The revenue in September for Zinzino's sales markets increased by 10% to SEK 111.6 (101.7) million due to solid growth in several regions. Faun Pharma's external sales increased by 13% and amounted to SEK 6.2 (5.5) million. Overall, the Group increased revenues by 10% to SEK 117.8 (107.2) million compared with the previous year. The third quarter of 2021 became a solid quarter; the Zinzino based revenue in July – September increased by 11% to SEK 298.8 (269.0) million Tudjon meg többet »

Közzétett: 5 okt. PDF letöltése


ZINZINO AB (PUBL): Zinzino announces launch of Taiwan as next step in the global expansion

The global, direct selling company within test-based, scientifically proven nutrition is very proud to announce the launch of its business in Taiwan on September 9, 2021 as a strategic part of the company’s mission towards global expansion. After several years of preparing the launch of the Taiwan market and having carried out multiple market establishment processes in recent years, Zinzino has learned the importance of ensuring thorough preparatory work and adapting to the local conditions in each market. Profitable growth is an important business strategy for the e-commerce-based Tudjon meg többet »

Közzétett: 9 szept. PDF letöltése


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT AUGUST 2021

Strong sales growth during August; Zinzino group revenue increased with a total of 14%, compared with the previous year. The revenue in August for Zinzino's sales markets increased by 13% to SEK 92.2 (81.9) million due to strong growth in several regions. Faun Pharma's external sales increased by 37% and amounted to SEK 4.8 (3.5) million. Overall, the Group increased revenues by 14% to SEK 97.0 (85.4) million compared with the previous year. Accumulated revenue for January – August 2021 increased by 23% to SEK 851.3 (690.9) million. Revenues were distributed as follows: Regions,MSEK Tudjon meg többet »

Közzétett: 3 szept. PDF letöltése


ZINZINO AB (PUBL): INTERIM REPORT SECOND QUARTER 2021

INCREASED PROFIT FORECAST AFTER ANOTHER STRONG QUARTER The second quarter of 2021 was yet another quarter in which good sales growth was combined with high profitability. Total revenues in the Group increased by 18% and amounted to SEK 322.4 (274.3) million. EBITDA result amounted to SEK 33.4 (16.0) million for the quarter and the EBITDA margin amounted to 10.4% (5.8%). The margin improvement is achieved through economies of scale due to improved efficiency in IT systems, logistics and within the organization. During the quarter, sales started in India, and Malaysia achieved full market Tudjon meg többet »

Közzétett: 27 aug. PDF letöltése


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JULY 2021

Strong sales growth during July; Zinzino group revenue increased with a total of 11%, compared with the previous year. The revenue in July for Zinzino's sales markets increased by 13% to SEK 96.3 (85.3) million due to strong growth in several regions. Faun Pharma's external sales decreased by 23% and amounted to SEK 3.0 (3.9) million. Overall, the Group increased revenues by 11% to SEK 99.3 (89.2) million compared with the previous year. Accumulated revenue for January – July 2021 increased by 25% to SEK 755.2 (605.5) million. Revenues were distributed as follows: Regions,MSEK Tudjon meg többet »

Közzétett: 5 aug. PDF letöltése


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q2 2021

Strong sales growth during Q2: Zinzino group revenue increased with a total of 17%, compared with the previous year. The revenue in June for Zinzino's sales markets increased by 8% to SEK 102.4 (94.6) million due to solid growth in several regions. Faun Pharma's external sales decreased by 28% and amounted to SEK 3.8 (5.3) million due to high internal production during the month. Overall, the Group increased revenues by 6% to SEK 106.2 (99.9) million compared with the previous year. The second quarter of 2021 became a strong quarter; the Zinzino based revenue in April - June increased 18% Tudjon meg többet »

Közzétett: 5 júl. PDF letöltése


ANNUAL REPORT ENGLISH 2020 ZINZINO AB (PUBL)

Zinzino (publ.) announces that the Annual Report for 2020 is now available for download in English at the company’s website, www.zinzino.com.   For more information: Fredrik Nielsen, CFO Zinzino + 46 (0) 707 900 174, zinzino.com Pictures for publication free of charge: Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollblom@zinzino.com Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se Tudjon meg többet »

Közzétett: 7 jún. PDF letöltése


ZINZINO AB (PUBL): PRELIMINARY SALES REPORT MAY 2021

Strong sales growth during May; Zinzino group revenue increased with a total of 26%, compared with the previous year. The revenue in May for Zinzino’s sales markets increased by 31% to SEK 104.3 (79.4) million due to strong growth in several regions. Faun Pharma's external sales decreased by 35% and amounted to SEK 4.5 (6.9) million. Overall, the Group increased revenues by 26% to SEK 108.8 (86.3) million compared with the previous year. Accumulated revenue for January – May 2021 increased by 32% to SEK 548.7 (416.5) million. Revenues were distributed as follows: Regions, MSEK Tudjon meg többet »

Közzétett: 3 jún. PDF letöltése